Supervisory Board Member
Dr. Norbert W. Bischofberger
Member of the Supervisory Board effective April 2017, elected until 2022
President and Chief Executive Officer at Kronos Bio, Inc.
Membership of comparable control bodies of corporations in Germany or abroad:
- Kronos Bio, Inc. (Board of Directors)**
- Morphic Therapeutic, Inc. (Board of Directors)**
** listed company
Curriculum Vitae
| January 10, 1956 | born in Mellau, Austria |
| 1975–1980 | Studies of chemistry at Leopold-Franzens-University, Innsbruck, Austria |
| 1980-1983 | Doctorate (Dr. rer. nat.) at the Eidgenössische Technische Hochschule Zurich, Switzerland |
| 1983–1984 | Postdoc at Syntex, Inc., Palo Alto, California, USA |
| 1984–1986 | Postdoc at Harvard University, Cambridge, Massachusetts, USA |
| 1986–1990 | Scientist in the Molecular Biology Department at Genentech Inc., South San Francisco, California, USA, from 1988 Manager DNA Synthesis |
| since 1990 | Gilead Sciences Inc., Foster City, California, USA |
| 1990 –1993 | Director Organic Chemistry |
| 1993–1995 | Vice President Organic Chemistry |
| 1995–1997 | Vice President Research |
| 1997–1999 | Senior Vice President Research |
| 1999–2007 | Senior Vice President Research and Development |
| 2007–2018 | Executive Vice President Research & Development and Chief Scientific Officer |
| since 2018 | President and Chief Executive Officer at Kronos Bio, Inc. |